platinum has been researched along with Cancer of Prostate in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.88) | 18.7374 |
| 1990's | 2 (5.88) | 18.2507 |
| 2000's | 3 (8.82) | 29.6817 |
| 2010's | 14 (41.18) | 24.3611 |
| 2020's | 13 (38.24) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, S; Wang, D; Yang, B | 1 |
| Barroca-Ferreira, J; Carvalho, M; Correa-Duarte, MA; Gomes, RM; Guillade, L; Maia, CJ; Moreira Rocha, S; Moreira, FTC; Passarinha, LA | 1 |
| Al-Saad, S; Boland, P; Bosse, D; Bryce, AH; Collier, K; Costello, BA; Eule, CJ; Hu, J; Lam, ET; Lewis, AR; McKay, RR; Mortazavi, A; Narayan, V; Rose, TL | 1 |
| Meftahi, M; Patel, P; Qiu, RLJ; Song, WY; Yang, X | 1 |
| Chee, G; Fu, J; Gao, Y; Hu, P; King, C; Kishan, AU; Lewis, JH; Ruan, D; Singhrao, K; Yang, Y | 1 |
| Fujisawa, M; Jimbo, N; Kimbara, S; Minami, H; Nakano, Y; Suzuki, K; Terakawa, T; Toyoda, M | 1 |
| Barbanente, A; Esposti, LD; Iafisco, M; Leeuwenburgh, SCG; Margiotta, N; Nadar, RA; Palazzo, B; van den Beucken, JJJP | 1 |
| Ahmed, HU; Barentsz, JO; Padhani, AR; Panebianco, V; Schoots, IG; Tempany, CMC; Villeirs, G; Weinreb, J | 1 |
| Barata, P; Cotogno, P; Harris, K; Layton, J; Ledet, E; Lewis, B; Manogue, C; Sartor, O | 1 |
| Arora, M; Meyers, FJ | 1 |
| Batter, S; Frank, RC; Kaplan, F; Kazanjian, M; Levy, G; Martignetti, J; Martino, C; Pandya, D; Shah, M | 1 |
| Abakumov, MA; Abdul Razak, IB; Aisa, HA; Akhmirov, RT; Aladinskaya, AV; Allem, JP; Allu, SR; Ambale-Venkatesh, B; Anasori, B; Arizcorreta, A; Armentrout, PB; Baumann, H; Beloglazkina, EK; Ben-Elyiahu, Y; Ber, AP; Berthon, C; Bettelheim, A; Bluemke, DA; Bonsignore, M; Bordet, A; Borruso, A; Boxer, MB; Bress, AP; Brimacombe, KR; Brown, DE; Brüggemann, M; Cafeo, A; Cao, K; Cao, L; Carnicelli, J; Carr, JC; Cavallo, L; Cazin, CSJ; Cheff, DM; Chen, G; Chen, H; Chen, J; Chen, R; Chen-Sankey, JC; Cheng, C; Cheng, Y; Cheruku, RR; Chida, N; Choi, K; Chu, M; Cipolli, M; Colantonio, LD; Collado, A; Cook, J; Cordes, DB; Covey, J; Cuesta-Sancho, S; Davis, MI; Demireva, M; Derington, CG; Di Rosa, G; Dicanio, D; Dong, G; Dontsova, OA; Dormanesh, A; Dovrat, G; Duan, XM; Duarte, DA; Efthymiou, S; Erofeev, AS; Falivene, L; Fang, Y; Feng, D; Fernandes, VRS; Finko, AV; Freitag, TM; Frye, S; Gachot, C; Gao, S; Garanina, AS; Getya, D; Girón-González, JA; Girón-Ortega, JA; Gitsov, I; Gorelkin, PV; Grützmacher, PG; Guo, PY; Gutiérrez-Saborido, D; Habibi, M; Hall, MD; Hayes-Ryan, D; He, ZZ; Henderson, MJ; Herrick, JS; Herrmann, H; Hoang, Y; Hofmann, W; Hollingshead, M; Houlden, H; Hu, L; Huang, B; Huang, Y; Hussain, M; Huynh, HP; Iansa, P; Ivanenkov, YA; Jadhav, A; Jalaludin, B; Jalava, P; Karavadhi, S; Karpasas, M; Katahara, S; Kawel-Boehm, N; Khazanova, ES; King, JB; Klumpp-Thomas, C; Knibbs, LD; Komiya, Y; Komppula, M; Kranidiotis-Hisatomi, N; Krasnovskaya, OO; Kwiezinski, C; Lee, SW; Lee, TD; Leitner, W; Lerner, A; Leskinen, A; Li, B; Li, J; Li, Y; Li, Z; Liang, D; Liao, HB; Lima, JAC; Lin, L; Lin, W; Lin, Z; Liu, H; Liu, K; Liu, L; Liu, Q; Liu, Y; Lu, K; Luo, M; Ma, B; Machulkin, AE; Maimon, E; Majouga, AG; Márquez-Coello, M; Martinez, NJ; McCarthy, C; McIver, A; Meaney, S; Melotti, P; Menin, L; Mertes, S; Michael, S; Missert, JR; Moisy, P; Monda, KL; Mondello, P; Moore, WJ; Mücklich, F; Mues, KE; Muntner, P; Nahra, F; Navar, AM; Nelson, DJ; Nelson, RE; Ni, S; Nicotera, AG; Nimenko, EA; Nolan, SP; O'Donoghue, K; Oestreich, M; Pandey, RK; Pang, RD; Patnaik, S; Pei, W; Petrov, SA; Pevzner, S; Phillips, KS; Pintani, E; Pironti, E; Pokrovsky, VS; Polshakov, VI; Poudel, B; Pragani, R; Presser, V; Qu, H; Rahsepar, AA; Ramsey, MW; Ravotto, L; Ren, D; Ren, G; Ren, L; Rogach, AL; Rohde, JM; Roponen, M; Rosen, BD; Rosenkranz, A; Rosenson, RS; Salpietro, V; Saltykova, IV; Sato, T; Saveliev, OY; Senger, AR; Shafikov, RR; Shataer, D; Shen, M; Shi, Y; Shu, X; Simeonov, A; Skvortsov, DA; Slawin, AMZ; Smirnova, GB; Song, G; Stevens, VW; Stott, GM; Stratmann, F; Su, BJ; Suarez, S; Sugiyama, Y; Tabaczynski, W; Teo, KL; Tolosa, A; Totorika, A; Tracy, EC; Treggiari, D; Tridello, G; Troxler, T; Urban, DJ; Uspenskaya, AA; Vainer, R; Van Hecke, K; van Pinxteren, D; Vanden Broeck, SMP; Vanneman, ME; Vinogradov, SA; Wang, B; Wang, H; Wang, HS; Wang, L; Wang, R; Wang, X; Wang, YQ; Weller, C; Winkler-Heil, R; Xia, F; Xiao, F; Xin, XL; Xing, H; Xu, J; Xu, SL; Xu, Z; Yamane, M; Yamansarov, EU; Yan, T; Yang, BY; Yang, G; Yang, L; Yang, P; Yang, X; Yao, T; Yasgar, A; Ye, N; Yi, H; Yin, C; Yu, DYW; Yu, HY; Yu, J; Yuan, M; Zagefka, H; Zeng, XW; Zhang, H; Zhang, S; Zhang, W; Zhao, D; Zhao, W; Zhao, X; Zheng, H; Zheng, YK; Zhu, X; Zilbermann, I; Zyk, NU; Zyk, NV | 1 |
| Jeong, S; Kang, JM; Kim, CS; Kim, HB; Kim, JW; Kim, SH; Kim, Y; Lim, B; Park, JH; Park, Y; Ryu, DS; Won, DS | 1 |
| Armstrong, AJ; Humeniuk, MS; Zhang, T | 1 |
| Chen, J; Fu, B; Li, K; Liu, T | 1 |
| Arce-Gallego, S; Athie, A; Carles, J; Casals Galobart, T; Gonzalez, M; Hernandez Viedma, G; Mateo, J; Morales-Barrera, R; Suarez, C | 1 |
| McNabb, E; Noseworthy, MD; Wong, R | 1 |
| Bérubé, G; Côté, MF; Gaudreault, RC; Ouellette, V; Tajmir-Riahi, HA | 1 |
| Aparicio, AM; Arap, W; Araujo, JC; Corn, PG; Harzstark, AL; Kim, J; Logothetis, CJ; Mathew, P; Millikan, RE; Pagliaro, LC; Ryan, C; Tannir, NM; Thall, PF; Troncoso, P; Tu, SM; Wen, S; Zurita, AJ | 1 |
| Asselin, É; Bérubé, G; Brasseur, K; Fortin, S; Morin, N | 1 |
| Josowicz, M; Patterson, S; Saheb, A | 1 |
| Han, L; Huo, S; Ji, T; Jin, S; Kumar, A; Li, S; Liang, XJ; Liu, H; Liu, J; Tan, A; Tang, S; Wang, T; Xue, X; Zhang, J; Zhang, X; Zhao, Y; Zou, G | 1 |
| Abedi, A; Amani, V; Bozorgmehr, M; Lighvan, ZM; Mirzadegan, E; Mohammadi, F; Safari, N; Shahsavar, F; Zarnani, AH | 1 |
| James, ND; Ritchie, AWS; Sydes, MR | 1 |
| Adams, AA; Balamurugan, S; Dharmasiri, U; Obubuafo, A; Okagbare, PI; Soper, SA | 1 |
| Aguilera, RJ; Contel, M; González-Pantoja, JF; Jarzecki, AA; Robles-Escajeda, E; Royo, E; Stern, M; Varela-Ramírez, A | 1 |
| de Carvalho, AL; Lopes, RP; Marques, MP; Matos, CS | 1 |
| Sillerud, LO; Taylor, RM | 1 |
| Brard, L; Kim, KK; Lange, TS; Shaw, SK; Singh, RK | 1 |
| Akimoto, M; Kawai, H; Kawamura, N; Nakajima, H; Nishimura, T; Tomita, M; Tsuboi, N; Yoshida, K; Yui, Y | 1 |
| Awad, SA; Eastwood, BJ; el-Araby, AA; Joseph, PK; Lannon, SG | 1 |
| Johannes, WU; Miller, GJ; Moffatt, KA | 1 |
| DiBiase, SJ; Sutlief, S; Tralins, K; Wallner, K | 1 |
| Block, NL; Camuzzi, F; Claflin, A; Politano, VA; Stover, B; Troner, M | 1 |
2 review(s) available for platinum and Cancer of Prostate
| Article | Year |
|---|---|
Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer.
Topics: Antineoplastic Agents, Immunological; DNA Repair; Humans; Male; Mutation; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Precision Medicine; Prostatic Neoplasms; Receptors, Androgen | 2019 |
New strategies against prostate cancer--Pt(II)-based chemotherapy.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Male; Organoplatinum Compounds; Oxaliplatin; Platinum; Prostatic Neoplasms | 2012 |
32 other study(ies) available for platinum and Cancer of Prostate
| Article | Year |
|---|---|
Re: Vicenç Ruiz de Porras, Xieng C. Wang, Luis Palomero, et al. Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment. Eur Urol 2021;79:722-33.
Topics: Bridged-Ring Compounds; Humans; Male; Platinum; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids | 2021 |
Development of a novel electrochemical biosensor based on plastic antibodies for detection of STEAP1 biomarker in cancer.
Topics: Antibodies; Antigens, Neoplasm; Biomarkers; Biosensing Techniques; Electrochemical Techniques; Electrodes; Humans; Male; Metal Nanoparticles; Molecular Imprinting; Nanotubes, Carbon; Oxidoreductases; Plastics; Platinum; Prostatic Neoplasms; Reproducibility of Results | 2023 |
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.
Topics: Aged; Humans; Male; Middle Aged; Platinum; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies | 2023 |
A novel direction modulated brachytherapy technique for urethra sparing in high-dose-rate brachytherapy of prostate cancer.
Topics: Brachytherapy; Humans; Male; Organs at Risk; Platinum; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Urethra | 2023 |
Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
Topics: Computer Simulation; Fiducial Markers; Gold; Humans; Iron; Magnetic Resonance Imaging; Male; Phantoms, Imaging; Platinum; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2020 |
Amrubicin for Patients With Platinum-refractory Small-cell Prostate Cancer: Two Case Reports.
Topics: Aged; Anthracyclines; Antineoplastic Agents; Carcinoma, Small Cell; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Platinum; Prognosis; Prostatic Neoplasms | 2020 |
Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells.
Topics: Adsorption; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Coculture Techniques; Drug Liberation; Drug Screening Assays, Antitumor; Durapatite; Humans; Kinetics; Male; Nanoparticles; Particle Size; Platinum; Prostatic Neoplasms; Selenium; Stem Cells; Surface Properties; Tumor Cells, Cultured | 2020 |
Platinum Opinion Counterview: The Evidence Base for the Benefit of Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis is Sound.
Topics: Humans; Magnetic Resonance Imaging; Male; Platinum; Prostatic Neoplasms | 2020 |
Long-Term Disease Control Using Taxane/Platinum-Based Chemotherapy in CDK12-Mutated Advanced Prostate Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinases; Humans; Male; Platinum; Prostatic Neoplasms; Taxoids | 2020 |
Homologous Recombination DNA Repair Gene Aberrations-Are We More Alike Than Different?
Topics: DNA Repair; Humans; Male; Platinum; Prostatic Neoplasms; Recombinational DNA Repair | 2020 |
Treatment-emergent neuroendocrine prostate cancer with a germline
Topics: Aged; Androstenes; Antineoplastic Agents; BRCA1 Protein; BRCA2 Protein; Drug Resistance, Neoplasm; Drug Therapy; Genes, BRCA1; Genes, BRCA2; Germ Cells; Humans; Male; Mutation; Phthalazines; Piperazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Prostatic Neoplasms | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antigens, Surface; Antineoplastic Agents; Antioxidants; Antiviral Agents; Aporphines; Atherosclerosis; Benzoyl Peroxide; beta Catenin; Biofilms; Biomarkers; Brain; Cannabis; Carcinoma, Squamous Cell; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Child; China; Chlorides; Chlorophyll; Cholesterol, LDL; Coinfection; Corylus; Cross-Sectional Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Developmental Disabilities; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Electroencephalography; Environmental Exposure; Enzyme Inhibitors; Epilepsy, Generalized; Ethnicity; Female; Fertilization in Vitro; Fluorescent Dyes; Follow-Up Studies; Forecasting; Glutamate Carboxypeptidase II; Glycine; Half-Life; Head and Neck Neoplasms; Health Communication; Heart Ventricles; Hepacivirus; Hepatitis C; Heterosexuality; HIV Infections; Humans; Hypercholesterolemia; Immunoassay; Inhalation Exposure; Isocitrate Dehydrogenase; Laryngeal Neoplasms; Ligands; Light; Lipopolysaccharide Receptors; Liver Cirrhosis; Lung; Lung Neoplasms; Magnetic Resonance Imaging, Cine; Male; Maternal Age; Mechanical Phenomena; Mice; Mice, Nude; Mice, SCID; Microglia; MicroRNAs; Microscopy, Fluorescence; Microsomes, Liver; Middle Aged; Minority Groups; Mitochondrial Membrane Transport Proteins; Models, Biological; Molecular Structure; Molecular Weight; Monte Carlo Method; Muscle Hypotonia; Mutagenesis, Site-Directed; Mutation, Missense; Natriuretic Peptide, Brain; Neoplasms; Nickel; Nitric Oxide; Optical Imaging; Oxides; Particle Size; Particulate Matter; PCSK9 Inhibitors; Peptide Fragments; Phenotype; Photochemotherapy; Photosensitizing Agents; Phytochemicals; Piper; Placenta Growth Factor; Plant Extracts; Plant Leaves; Plant Stems; Platinum; Point-of-Care Testing; Population Surveillance; Postpartum Period; Pregnancy; Pregnancy, Twin; Prevalence; Prospective Studies; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyridines; Pyridones; Racial Groups; Rats; Respiratory Physiological Phenomena; Retrospective Studies; Risk Factors; RNA, Long Noncoding; Semiconductors; Sexual and Gender Minorities; Sexual Behavior; Social Media; Sodium; Solubility; Stereoisomerism; Stochastic Processes; Structure-Activity Relationship; Substance-Related Disorders; Sustained Virologic Response; Sweat; Temperature; Time Factors; Tissue Distribution; Titanium; Transplantation, Heterologous; Tumor Cells, Cultured; Tungsten; Tyramine; United States; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Function, Left; Veterans; Xenograft Model Antitumor Assays; Young Adult | 2021 |
Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate.
Topics: Ablation Techniques; Animals; Dogs; Electric Power Supplies; Electrodes; Electroporation; Male; Platinum; Prostate; Prostatic Neoplasms | 2021 |
Exploiting DNA damage without repair: The activity of platinum chemotherapy in BRCA-mutated prostate cancers.
Topics: BRCA2 Protein; DNA Damage; Germ Cells; Humans; Male; Platinum; Prostatic Neoplasms | 2017 |
An electrochemical sarcosine sensor based on biomimetic recognition.
Topics: Biomarkers, Tumor; Biomimetic Materials; Biosensing Techniques; Chitosan; Electrochemical Techniques; Electrodes; Gold; Graphite; Humans; Limit of Detection; Male; Metal Nanoparticles; Particle Size; Platinum; Prostatic Neoplasms; Pyrroles; Riboflavin; Sarcosine; Sarcosine Oxidase; Surface Properties | 2019 |
Differentiating platinum coated brachytherapy seeds and gold fiducial markers with varying off-resonant frequency offsets.
Topics: Agar; Brachytherapy; Color; Computer Simulation; Contrast Media; Fiducial Markers; Gold; Humans; Magnetic Resonance Imaging; Male; Models, Theoretical; Phantoms, Imaging; Platinum; Prostatic Neoplasms; Prostheses and Implants; Reproducibility of Results; Tomography, X-Ray Computed | 2019 |
Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Organoplatinum Compounds; Platinum; Prostatic Neoplasms; Receptors, Androgen; Structure-Activity Relationship; Testosterone | 2019 |
Platinum-based chemotherapy for variant castrate-resistant prostate cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Middle Aged; Orchiectomy; Platinum; Prostatic Neoplasms; Treatment Outcome | 2013 |
New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: design, synthesis, structure-activity relationships and biological evaluation.
Topics: Animals; Antineoplastic Agents; Biological Assay; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Drug Design; Humans; Inhibitory Concentration 50; Male; Models, Animal; Organometallic Compounds; Platinum; Prostatic Neoplasms; Structure-Activity Relationship; Testosterone | 2013 |
Probing for DNA methylation with a voltammetric DNA detector.
Topics: Base Sequence; Biomarkers, Tumor; Biosensing Techniques; DNA; DNA Methylation; DNA, Single-Stranded; Electrochemical Techniques; Electrochemistry; Glutathione S-Transferase pi; Humans; Male; Microelectrodes; Nucleic Acid Hybridization; Platinum; Polymers; Promoter Regions, Genetic; Prostatic Neoplasms; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Static Electricity | 2014 |
Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Drug Carriers; Drug Resistance, Neoplasm; Glutathione; Gold; Humans; Male; Metal Nanoparticles; Microscopy, Electron, Transmission; Neuropilin-1; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Peptides; Platinum; Prostatic Neoplasms; Protein Binding; Surface Properties; Ultraviolet Rays | 2014 |
A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Topics: 2,2'-Dipyridyl; Amniotic Fluid; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Dimethylformamide; DNA; Drug Resistance, Neoplasm; Epithelial Cells; Female; Humans; Intercalating Agents; Male; MCF-7 Cells; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Prostatic Neoplasms; Spectrophotometry | 2016 |
Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707-708.
Topics: Attitude; Docetaxel; Humans; Male; Platinum; Prostatic Neoplasms; Taxoids | 2017 |
Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device.
Topics: Antibodies, Immobilized; Antibodies, Monoclonal; Aptamers, Peptide; Cell Count; Cell Line, Tumor; Cell Separation; Humans; Linear Models; Male; Microelectrodes; Microfluidic Analytical Techniques; Microscopy, Fluorescence; Models, Biological; Neoplastic Cells, Circulating; Platinum; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity | 2009 |
Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Circular Dichroism; DNA; Female; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Nucleic Acid Conformation; Organometallic Compounds; Palladium; Phosphines; Platinum; Prostatic Neoplasms; Spectrophotometry, Infrared; Structure-Activity Relationship; Titanium; Uterine Cervical Neoplasms | 2011 |
Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.
Topics: Animals; Antibodies; Antigens, Surface; Antineoplastic Agents, Phytogenic; Cell Growth Processes; Cell Line, Tumor; Contrast Media; Glutamate Carboxypeptidase II; Humans; Immunoconjugates; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Mice, Nude; Micelles; Paclitaxel; Particle Size; Platinum; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2012 |
A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.
Topics: Adenocarcinoma; Apoptosis; Biomarkers; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activation; Female; Humans; Indoles; Isocyanates; Male; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Pancreatic Neoplasms; Platinum; Prostatic Neoplasms | 2008 |
[Heterotransplantation of human malignant urogenital tumors. (3) Basic studies of transplantable human prostatic carcinoma in nude mice and susceptibility testing of several platinum compounds (author's transl)].
Topics: Animals; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Platinum; Prostatic Neoplasms; Receptors, Cell Surface; Transplantation, Heterologous | 1982 |
Long-term results of combined interstitial gold seed implantation plus external beam irradiation in localised carcinoma of the prostate.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Brachytherapy; Follow-Up Studies; Gold Radioisotopes; Humans; Male; Middle Aged; Neoplasm Staging; Platinum; Prostate; Prostatic Neoplasms; Survival Rate | 1993 |
1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Calcitriol; Carboplatin; Cell Cycle; Cell Division; Cholecalciferol; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Humans; Male; Platinum; Prostatic Neoplasms; Tumor Cells, Cultured | 1999 |
Brachytherapy radiation doses to the neurovascular bundles.
Topics: Brachytherapy; Erectile Dysfunction; Humans; Iodine Radioisotopes; Male; Physical Phenomena; Physics; Platinum; Prostate; Prostatic Neoplasms; Radiation Dosage; Radiation Injuries; Radioisotopes; Reproducibility of Results; Tomography, X-Ray Computed | 2000 |
Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Hybridization, Genetic; Hydroxyurea; Lomustine; Male; Methotrexate; Neoplasms, Experimental; Platinum; Prostatic Neoplasms; Rats | 1978 |